Biogen, the biotechnology company behind the Alzheimer’s drug Aduhelm, announced on Wednesday that it would stop selling and developing the drug, which had faced criticism and...
Biogen, the biotechnology company behind the Alzheimer’s drug Aduhelm, announced on Wednesday that it would stop selling and developing the drug, which had faced criticism and...